Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 37

1.

Targeting PRPK and TOPK for skin cancer prevention and therapy.

Roh E, Lee MH, Zykova TA, Zhu F, Nadas J, Kim HG, Bae KB, Li Y, Cho YY, Curiel-Lewandrowski C, Einspahr J, Dickinson SE, Bode AM, Dong Z.

Oncogene. 2018 Oct;37(42):5633-5647. doi: 10.1038/s41388-018-0350-9. Epub 2018 Jun 14.

2.

Targeting PRPK Function Blocks Colon Cancer Metastasis.

Zykova T, Zhu F, Wang L, Li H, Lim DY, Yao K, Roh E, Yoon SP, Kim HG, Bae KB, Wen W, Shin SH, Nadas J, Li Y, Ma W, Bode AM, Dong Z.

Mol Cancer Ther. 2018 May;17(5):1101-1113. doi: 10.1158/1535-7163.MCT-17-0628. Epub 2018 Feb 26.

3.

15-Deoxy-Δ12,14-prostaglandin J2 stabilizes hypoxia inducible factor-1α through induction of heme oxygenase-1 and direct modification ofprolyl-4-hydroxylase 2.

Choi JE, Kim JH, Song NY, Suh J, Kim DH, Kim SJ, Na HK, Nadas J, Dong Z, Cha YN, Surh YJ.

Free Radic Res. 2016 Oct;50(10):1140-1152. Epub 2016 Sep 6.

PMID:
27598034
4.

[Neurovascular compression of the medulla oblongata: a rare cause of secondary hypertension].

Nádas J, Czirják S, Igaz P, Vörös E, Jermendy G, Rácz K, Tóth M.

Orv Hetil. 2014 May 25;155(21):838-42. doi: 10.1556/OH.2014.29908. Hungarian.

PMID:
24836320
5.

Design criteria for polyazine extractants to separate An(III) from Ln(III.).

de Sahb C, Watson LA, Nadas J, Hay BP.

Inorg Chem. 2013 Sep 16;52(18):10632-42. doi: 10.1021/ic401666m. Epub 2013 Aug 23.

PMID:
23971900
6.

Screening for metabolic syndrome within a minority ethnic group (adult Gypsy people) in Hungary.

Hidvegi T, Hetyesi K, Biro L, Nadas J, Jermendy G.

Bratisl Lek Listy. 2012;113(12):721-4.

PMID:
23173631
7.

Ceftriaxone, an FDA-approved cephalosporin antibiotic, suppresses lung cancer growth by targeting Aurora B.

Li X, Li H, Li S, Zhu F, Kim DJ, Xie H, Li Y, Nadas J, Oi N, Zykova TA, Yu DH, Lee MH, Kim MO, Wang L, Ma W, Lubet RA, Bode AM, Dong Z, Dong Z.

Carcinogenesis. 2012 Dec;33(12):2548-57. doi: 10.1093/carcin/bgs283. Epub 2012 Sep 7.

8.

Prediction of molecular targets of cancer preventing flavonoid compounds using computational methods.

Chen H, Yao K, Nadas J, Bode AM, Malakhova M, Oi N, Li H, Lubet RA, Dong Z.

PLoS One. 2012;7(5):e38261. doi: 10.1371/journal.pone.0038261. Epub 2012 May 31.

9.

ERK1 and ERK2 regulate embryonic stem cell self-renewal through phosphorylation of Klf4.

Kim MO, Kim SH, Cho YY, Nadas J, Jeong CH, Yao K, Kim DJ, Yu DH, Keum YS, Lee KY, Huang Z, Bode AM, Dong Z.

Nat Struct Mol Biol. 2012 Feb 5;19(3):283-90. doi: 10.1038/nsmb.2217.

PMID:
22307056
10.

Assessment of cardiometabolic risk among shift workers in Hungary.

Jermendy G, Nádas J, Hegyi I, Vasas I, Hidvégi T.

Health Qual Life Outcomes. 2012 Feb 1;10:18. doi: 10.1186/1477-7525-10-18.

11.

(3-Chloroacetyl)-indole, a novel allosteric AKT inhibitor, suppresses colon cancer growth in vitro and in vivo.

Kim DJ, Reddy K, Kim MO, Li Y, Nadas J, Cho YY, Kim JE, Shim JH, Song NR, Carper A, Lubet RA, Bode AM, Dong Z.

Cancer Prev Res (Phila). 2011 Nov;4(11):1842-51. doi: 10.1158/1940-6207.CAPR-11-0158. Epub 2011 Sep 1.

12.

Shapes of sulfur, oxygen, and nitrogen mustards.

Nadas J, Zhang X, Hay BP.

J Phys Chem A. 2011 Jun 23;115(24):6709-16. doi: 10.1021/jp203120c. Epub 2011 Jun 1.

PMID:
21591645
13.

Introduction of aromatic group on 4'-OH of α-GalCer manipulated NKT cell cytokine production.

Zhang W, Xia C, Nadas J, Chen W, Gu L, Wang PG.

Bioorg Med Chem. 2011 Apr 15;19(8):2767-76. doi: 10.1016/j.bmc.2010.11.061. Epub 2010 Dec 2.

PMID:
21439833
14.

Eriodictyol inhibits RSK2-ATF1 signaling and suppresses EGF-induced neoplastic cell transformation.

Liu K, Cho YY, Yao K, Nadas J, Kim DJ, Cho EJ, Lee MH, Pugliese A, Zhang J, Bode AM, Dong Z, Dong Z.

J Biol Chem. 2011 Jan 21;286(3):2057-66. doi: 10.1074/jbc.M110.147306. Epub 2010 Nov 22.

15.

Resveratrol, a red wine polyphenol, suppresses pancreatic cancer by inhibiting leukotriene A₄hydrolase.

Oi N, Jeong CH, Nadas J, Cho YY, Pugliese A, Bode AM, Dong Z.

Cancer Res. 2010 Dec 1;70(23):9755-64. doi: 10.1158/0008-5472.CAN-10-2858. Epub 2010 Oct 15.

16.

Prevalence rate of diabetes mellitus and impaired fasting glycemia in Hungary: cross-sectional study on nationally representative sample of people aged 20-69 years.

Jermendy G, Nádas J, Szigethy E, Széles G, Nagy A, Hídvégi T, Paragh G, Adány R.

Croat Med J. 2010 Apr;51(2):151-6.

17.

The roles of 3' and 4' hydroxy groups in alpha-galactosylceramide stimulation of invariant natural killer T cells.

Xia C, Zhang W, Zhang Y, Chen W, Nadas J, Severin R, Woodward R, Wang B, Wang X, Kronenberg M, Wang PG.

ChemMedChem. 2009 Nov;4(11):1810-5. doi: 10.1002/cmdc.200900350. No abstract available.

18.

Computational structure activity relationship studies on the CD1d/glycolipid/TCR complex using AMBER and AUTODOCK.

Nadas J, Li C, Wang PG.

J Chem Inf Model. 2009 Feb;49(2):410-23. doi: 10.1021/ci8002705.

PMID:
19434842
19.

[From the metabolic syndrome to the concept of global cardiometabolic risk].

Nádas J, Jermendy G.

Orv Hetil. 2009 May 3;150(18):821-9. doi: 10.1556/OH.2009.28606. Review. Hungarian.

PMID:
19383573
20.

Cardiovascular risk factors characteristic for the metabolic syndrome in adult patients with type 1 diabetes.

Nádas J, Putz Z, Fövényi J, Gaál Z, Gyimesi A, Hídvégi T, Hosszúfalusi N, Neuwirth G, Oroszlán T, Pánczél P, Széles G, Vándorfi G, Winkler G, Wittmann I, Jermendy G.

Exp Clin Endocrinol Diabetes. 2009 Mar;117(3):107-12. doi: 10.1055/s-0028-1082068. Epub 2009 Mar 10.

PMID:
19277931

Supplemental Content

Loading ...
Support Center